Innoviva (INVA) Revenue (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,931.71% |
| Dec 31, 2025 | -98.99% |
| Sep 30, 2025 | 7.50% |
| Jun 30, 2025 | 13.15% |
| Mar 31, 2025 | 7,076.68% |
| Dec 31, 2024 | -98.62% |
| Sep 30, 2024 | -10.40% |
| Jun 30, 2024 | 10,241.41% |
| Mar 31, 2024 | -36.78% |
| Dec 31, 2023 | -97.73% |
| Sep 30, 2023 | 6,763.16% |
| Jun 30, 2023 | 23.12% |
| Mar 31, 2023 | -24.26% |
| Dec 31, 2022 | -19.15% |
| Sep 30, 2022 | -30.96% |
| Jun 30, 2022 | 52.35% |
| Mar 31, 2022 | 24.97% |
| Dec 31, 2021 | -98.99% |
| Sep 30, 2021 | 8,278.60% |
| Jun 30, 2021 | 9.57% |
| Mar 31, 2021 | 111.51% |
| Dec 31, 2020 | -99.43% |
| Sep 30, 2020 | 12.35% |
| Jun 30, 2020 | 0.34% |
| Mar 31, 2020 | 3.56% |
| Dec 31, 2019 | 15.54% |
| Sep 30, 2019 | 2.57% |
| Jun 30, 2019 | 16.17% |
| Mar 31, 2019 | -30.90% |
| Dec 31, 2018 | 29.47% |
| Sep 30, 2018 | -8.06% |
| Jun 30, 2018 | 28.08% |
| Mar 31, 2018 | -24.65% |
| Dec 31, 2017 | 42.92% |
| Sep 30, 2017 | -16.94% |
| Jun 30, 2017 | 44.63% |
| Mar 31, 2017 | -7.15% |
| Dec 31, 2016 | 30.93% |
| Sep 30, 2016 | 2.58% |
| Jun 30, 2016 | 34.32% |
| Mar 31, 2016 | 5.87% |
| Dec 31, 2015 | 68.38% |
| Sep 30, 2015 | 27.28% |
| Jun 30, 2015 | 54.51% |
| Mar 31, 2015 | -5.27% |
| Dec 31, 2014 | 628.73% |
| Sep 30, 2014 | 6.96% |
| Jun 30, 2014 | 19.74% |
| Mar 31, 2014 | -47.05% |
| Dec 31, 2013 | 254.94% |
| Sep 30, 2013 | -68.61% |
| Jun 30, 2013 | 0.00% |
| Mar 31, 2013 | 101.06% |
| Dec 31, 2012 | -8,795.59% |
| Sep 30, 2012 | 173.42% |
| Jun 30, 2012 | -99.58% |
| Mar 31, 2012 | 2,246.14% |
| Dec 31, 2011 | -16.62% |
| Sep 30, 2011 | 0.66% |
| Jun 30, 2011 | 0.92% |